Purpose We evaluated the effect of multi-month dispensing (MMD) on viral suppression
among newly enrolled adolescents and adults with HIV in 11 northern Nigerian states …

Background: Few studies in sub-Saharan Africa have assessed the impact of multimonth
dispensing (MMD) of antiretroviral therapy (ART) and dolutegravir (DTG) beyond clinical …

Introduction Multimonth dispensing (MMD) enables less frequent clinic visits and improved
outcomes for people living with HIV, but few children and adolescents living with HIV …

Background HIV low-level viremia (LLV)(51–999 copies/mL) can progress to treatment
failure and increase potential for drug resistance. We analyzed retrospective longitudinal …

Objectives: This study aimed at assessing adherence, effectiveness, and safety of DTG-
based HAART regimens among HIV-infected children and adolescents in Tanzania …

Background Toxicity, treatment failure, and resistance to existing HIV treatment regimens
have become a challenge in resource-limited settings. As a result, a dolutegravir based …

Background: The real-world impact on viral suppression of switching from non–dolutegravir-
based therapy to tenofovir/lamivudine/dolutegravir (TLD) is not thoroughly characterized in …

Background: Service delivery models for differentiated care provide a balanced approach to
HIV services using longer dispensing intervals for patients who are stable and virologically …

Background HIV is one of the leading causes of morbidity and mortality, with 39.0 million
people living with HIV worldwide, 25.6 million of whom reside in the African region. Highly …

During the COVID-19 pandemic, HIV programs scaled up differentiated service delivery
(DSD) models for people living with HIV (PLHIV). We evaluated the effects of COVID-19 on …